The Advisory Board Company Reports Fiscal Year 2008 Third Quart...(idered as an indication of future perfor...),Health

Date:2/5/2008

idered as an indication of future performance. Factors that could cause actual results to differ materially from those indicated by forward-looking statements include, among others, the dependence on renewal of membership-based services, dependence on key personnel, the need to attract and retain qualified personnel, management of growth, new product development, competition, risks associated with anticipating market trends, industry consolidation, variability of quarterly operating results, possible volatility in the Company's stock price, the impact on our financials associated with some of our newer programs that are more dependent upon technology, share-based compensation expense under SFAS No. 123R including the effect of the amount, type and timing of future stock- based compensation grants, and various factors related to income and other taxes, including whether the District of Columbia withdraws the Company's status as a Qualified High-Tech Company, as well as those risks and uncertainties described in the Company's Annual Report on Form 10-K for the fiscal year ended March 31, 2007 and also disclosed from time to time in its subsequent reports on Form 10-Q and Form 8-K, which are available on the Company's website at http://www.advisoryboardcompany.com in the "Investor Relations" section and at the SEC's website at http://www.sec.gov. Additional information will also be set forth in the Company's report on Form 10-Q for the quarter ended December 31, 2007, which will be filed with the SEC in February 2008.

Accordingly, readers are cautioned not to place undue reliance on forward- looking statements made in this news release, which speak only as of the date of this press release, and the Company does not undertake to update these statements, whether as a result of circumstances or events that arise after the date they are made, new informatio
'/>"/>

SOURCE The Advisory Board Company Copyright©2008 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
Related medicine news :

1. Nastech Appoints MDRNA, Inc. Directors Strategic Advisory Board
2. Dr. Warren Jackman Joins CryoCor Scientific Advisory Board
3. OSHA Seeking Nominations for National Advisory Committee on Occupational Safety and Health
4. National Institutes of Health Appoints Timothy C. Birdsall, ND to CAM Advisory Council
5. Manhattan Research: ePharma Consumer(R) Research and Advisory Service Now Available
6. The Advisory Board Company Schedules Third Quarter Investor Conference Call for February 5, 2008
7. Statement from the Consumer Healthcare Products Association on Todays FDA Advisory Committee Meeting on the Efficacy of Phenylephrine in the 10 Mg Oral Dose
8. American Society for Aesthetic Plastic Surgery and American Society of Plastic Surgeons Offer Patient Advisory for those Affected by Fig LipoDissolve Closures
9. FDA Advisory Panel Finds Hologics Adiana(R) Permanent Contraception Approvable
10. Bradmer announces additions to Scientific Advisory Board
11. Antibody Engineering Company f-star Appoints Three Pioneers in Antibody Engineering and Development to its Newly Established Scientific Advisory Board